

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.45329124 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 4.56308623 |
| 3 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.55508045 |
| 4 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.38820655 |
| 5 | DNA strand elongation (GO:0022616) | 4.32417005 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.27102474 |
| 7 | DNA replication initiation (GO:0006270) | 3.97537242 |
| 8 | DNA unwinding involved in DNA replication (GO:0006268) | 3.90773336 |
| 9 | viral transcription (GO:0019083) | 3.90224119 |
| 10 | nucleobase biosynthetic process (GO:0046112) | 3.85873163 |
| 11 | maturation of SSU-rRNA (GO:0030490) | 3.80848538 |
| 12 | ribosome biogenesis (GO:0042254) | 3.80766125 |
| 13 | translational termination (GO:0006415) | 3.80554879 |
| 14 | telomere maintenance via recombination (GO:0000722) | 3.79598143 |
| 15 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.61264208 |
| 16 | purine nucleobase biosynthetic process (GO:0009113) | 3.59625563 |
| 17 | protein localization to kinetochore (GO:0034501) | 3.56348602 |
| 18 | IMP biosynthetic process (GO:0006188) | 3.56028015 |
| 19 | translational elongation (GO:0006414) | 3.55367765 |
| 20 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.54495943 |
| 21 | translational initiation (GO:0006413) | 3.48052146 |
| 22 | protein maturation by protein folding (GO:0022417) | 3.47670376 |
| 23 | ribosomal small subunit biogenesis (GO:0042274) | 3.43608998 |
| 24 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.43331608 |
| 25 | mitotic recombination (GO:0006312) | 3.42588234 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.38786796 |
| 27 | telomere maintenance via telomere lengthening (GO:0010833) | 3.37430561 |
| 28 | ribosome assembly (GO:0042255) | 3.34954638 |
| 29 | rRNA modification (GO:0000154) | 3.33800438 |
| 30 | IMP metabolic process (GO:0046040) | 3.32210466 |
| 31 | pseudouridine synthesis (GO:0001522) | 3.31719306 |
| 32 | base-excision repair, AP site formation (GO:0006285) | 3.30864883 |
| 33 | DNA replication checkpoint (GO:0000076) | 3.27542525 |
| 34 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.25225107 |
| 35 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.25114705 |
| 36 | ribosomal large subunit biogenesis (GO:0042273) | 3.23193260 |
| 37 | rRNA processing (GO:0006364) | 3.22524793 |
| 38 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.22132693 |
| 39 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.18193741 |
| 40 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.17772650 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 3.15966911 |
| 42 | response to peptidoglycan (GO:0032494) | 3.15724883 |
| 43 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.15638836 |
| 44 | modulation by virus of host process (GO:0019054) | 3.13604497 |
| 45 | rRNA metabolic process (GO:0016072) | 3.09358888 |
| 46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09034687 |
| 47 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.06947411 |
| 48 | cellular response to arsenic-containing substance (GO:0071243) | 3.05895315 |
| 49 | protein localization to chromosome, centromeric region (GO:0071459) | 3.05056919 |
| 50 | proteasome assembly (GO:0043248) | 3.05026246 |
| 51 | spliceosomal snRNP assembly (GO:0000387) | 3.04675033 |
| 52 | mitotic nuclear envelope disassembly (GO:0007077) | 3.04514189 |
| 53 | protein targeting to ER (GO:0045047) | 3.03796463 |
| 54 | cotranslational protein targeting to membrane (GO:0006613) | 3.03321979 |
| 55 | viral life cycle (GO:0019058) | 3.03126127 |
| 56 | modulation by symbiont of host cellular process (GO:0044068) | 3.01832950 |
| 57 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.01393696 |
| 58 | folic acid metabolic process (GO:0046655) | 3.00175364 |
| 59 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.00022197 |
| 60 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.98285992 |
| 61 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.98285992 |
| 62 | deoxyribonucleotide catabolic process (GO:0009264) | 2.94532271 |
| 63 | histone arginine methylation (GO:0034969) | 2.93485906 |
| 64 | cellular protein complex disassembly (GO:0043624) | 2.91582088 |
| 65 | CENP-A containing nucleosome assembly (GO:0034080) | 2.90771708 |
| 66 | protein localization to endoplasmic reticulum (GO:0070972) | 2.87469825 |
| 67 | mitotic metaphase plate congression (GO:0007080) | 2.87116524 |
| 68 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.85826780 |
| 69 | negative regulation of B cell apoptotic process (GO:0002903) | 2.85302171 |
| 70 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.85138490 |
| 71 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.85138490 |
| 72 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.85111962 |
| 73 | nuclear envelope reassembly (GO:0031468) | 2.85051079 |
| 74 | mitotic nuclear envelope reassembly (GO:0007084) | 2.85051079 |
| 75 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.80785004 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 2.80382475 |
| 77 | chromatin remodeling at centromere (GO:0031055) | 2.79703149 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 2.78763316 |
| 79 | deoxyribose phosphate catabolic process (GO:0046386) | 2.78365982 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77912089 |
| 81 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.77486018 |
| 82 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.77139375 |
| 83 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.76834424 |
| 84 | DNA replication-independent nucleosome organization (GO:0034724) | 2.76834424 |
| 85 | purine nucleotide salvage (GO:0032261) | 2.76720457 |
| 86 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.76360550 |
| 87 | GDP-mannose metabolic process (GO:0019673) | 2.75675712 |
| 88 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.75588937 |
| 89 | membrane disassembly (GO:0030397) | 2.75573738 |
| 90 | nuclear envelope disassembly (GO:0051081) | 2.75573738 |
| 91 | purine-containing compound salvage (GO:0043101) | 2.75273424 |
| 92 | iron-sulfur cluster assembly (GO:0016226) | 2.75182232 |
| 93 | metallo-sulfur cluster assembly (GO:0031163) | 2.75182232 |
| 94 | cellular response to virus (GO:0098586) | 2.75047988 |
| 95 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.74088039 |
| 96 | peptidyl-arginine methylation (GO:0018216) | 2.73500785 |
| 97 | peptidyl-arginine N-methylation (GO:0035246) | 2.73500785 |
| 98 | protein complex disassembly (GO:0043241) | 2.71494806 |
| 99 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.70709718 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70219719 |
| 101 | translation (GO:0006412) | 2.69390279 |
| 102 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.69217094 |
| 103 | rRNA methylation (GO:0031167) | 2.68732999 |
| 104 | termination of RNA polymerase II transcription (GO:0006369) | 2.68473726 |
| 105 | nucleotide salvage (GO:0043173) | 2.68456509 |
| 106 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.68246638 |
| 107 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.67849175 |
| 108 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.67403043 |
| 109 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.66117219 |
| 110 | NIK/NF-kappaB signaling (GO:0038061) | 2.64759015 |
| 111 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.63404358 |
| 112 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.62840015 |
| 113 | negative regulation of ligase activity (GO:0051352) | 2.62840015 |
| 114 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.62170416 |
| 115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62170416 |
| 116 | regulation of spindle organization (GO:0090224) | 2.62162209 |
| 117 | myeloid dendritic cell activation (GO:0001773) | 2.61855447 |
| 118 | cellular component biogenesis (GO:0044085) | 2.58241764 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.57810354 |
| 120 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.57793795 |
| 121 | mRNA splicing, via spliceosome (GO:0000398) | 2.57793795 |
| 122 | macromolecular complex disassembly (GO:0032984) | 2.57198879 |
| 123 | mRNA cleavage (GO:0006379) | 2.57180863 |
| 124 | mRNA catabolic process (GO:0006402) | 2.57114309 |
| 125 | RNA splicing, via transesterification reactions (GO:0000375) | 2.56930680 |
| 126 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.56617591 |
| 127 | cell cycle G1/S phase transition (GO:0044843) | 2.56617591 |
| 128 | response to muramyl dipeptide (GO:0032495) | 2.56407063 |
| 129 | rRNA transcription (GO:0009303) | 2.56336590 |
| 130 | establishment of viral latency (GO:0019043) | 2.56262956 |
| 131 | RNA catabolic process (GO:0006401) | 2.56240816 |
| 132 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.55881934 |
| 133 | base-excision repair (GO:0006284) | 2.55667867 |
| 134 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.54317589 |
| 135 | regulation of superoxide anion generation (GO:0032928) | 2.54156041 |
| 136 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.53738095 |
| 137 | neutrophil activation involved in immune response (GO:0002283) | 2.53715004 |
| 138 | amino sugar catabolic process (GO:0046348) | 2.53472289 |
| 139 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.53215733 |
| 140 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.52351514 |
| 141 | regulation of B cell apoptotic process (GO:0002902) | 2.52004855 |
| 142 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51908252 |
| 143 | transcription from mitochondrial promoter (GO:0006390) | 2.51078087 |
| 144 | negative regulation of RNA splicing (GO:0033119) | 2.50670693 |
| 145 | positive regulation by symbiont of host defense response (GO:0052509) | 2.50271258 |
| 146 | modulation by symbiont of host defense response (GO:0052031) | 2.50271258 |
| 147 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.50271258 |
| 148 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.50271258 |
| 149 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.50271258 |
| 150 | modulation by symbiont of host immune response (GO:0052553) | 2.50271258 |
| 151 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.49870761 |
| 152 | translesion synthesis (GO:0019985) | 2.49727902 |
| 153 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.48076449 |
| 154 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.47542155 |
| 155 | mismatch repair (GO:0006298) | 2.47039955 |
| 156 | ncRNA processing (GO:0034470) | 2.46667704 |
| 157 | pentose-phosphate shunt (GO:0006098) | 2.46198690 |
| 158 | telomere organization (GO:0032200) | 2.45958065 |
| 159 | cellular response to type I interferon (GO:0071357) | 2.44825493 |
| 160 | type I interferon signaling pathway (GO:0060337) | 2.44825493 |
| 161 | ncRNA 3-end processing (GO:0043628) | 2.43530293 |
| 162 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.41250182 |
| 163 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.40122200 |
| 164 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.39710918 |
| 165 | regulation of defense response to virus by virus (GO:0050690) | 2.38793615 |
| 166 | response to type I interferon (GO:0034340) | 2.36485201 |
| 167 | negative regulation of type I interferon production (GO:0032480) | 2.35916302 |
| 168 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.33971540 |
| 169 | T cell apoptotic process (GO:0070231) | 2.32950440 |
| 170 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.32685371 |
| 171 | T cell migration (GO:0072678) | 2.32440308 |
| 172 | pyrimidine-containing compound salvage (GO:0008655) | 2.31029764 |
| 173 | pyrimidine nucleoside salvage (GO:0043097) | 2.31029764 |
| 174 | response to protozoan (GO:0001562) | 2.30237074 |
| 175 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.29681413 |
| 176 | negative regulation of innate immune response (GO:0045824) | 2.27065644 |
| 177 | pinocytosis (GO:0006907) | 2.26869637 |
| 178 | ubiquinone biosynthetic process (GO:0006744) | 2.26106596 |
| 179 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.26104300 |
| 180 | positive regulation of T cell apoptotic process (GO:0070234) | 2.24799710 |
| 181 | regulation of chemokine biosynthetic process (GO:0045073) | 2.23656337 |
| 182 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.23501417 |
| 183 | tolerance induction (GO:0002507) | 2.23245562 |
| 184 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.22473502 |
| 185 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.22473502 |
| 186 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.20004717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.19965715 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.76190273 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71650066 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.85609033 |
| 5 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.64757346 |
| 6 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.58524175 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.50407515 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.50239750 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46242512 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.41247908 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.39879840 |
| 12 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.38273105 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.37780002 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.35149822 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.35044168 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.33499785 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.20580065 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15487011 |
| 19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.14743602 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06849454 |
| 21 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.05837097 |
| 22 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.05675854 |
| 23 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.96115915 |
| 24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93020736 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89757794 |
| 26 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.86608569 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.84997013 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.82037930 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.76876369 |
| 30 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75567333 |
| 31 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.73616828 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.73348866 |
| 33 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71143253 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69375055 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.66535830 |
| 36 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.65264816 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62990459 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.62050037 |
| 39 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.61819844 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60175328 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57991312 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.57844204 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57716140 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.54298569 |
| 45 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51536998 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.50644739 |
| 47 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50385907 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.50200573 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49657634 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46994755 |
| 51 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46291566 |
| 52 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45874582 |
| 53 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.45594823 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.44290767 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.44147519 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44109614 |
| 57 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.43018074 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.41294233 |
| 59 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.40157892 |
| 60 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.39726342 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38752618 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36438275 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36424900 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35900708 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.35696898 |
| 66 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35636884 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35564367 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35146921 |
| 69 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33062124 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32305465 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31100068 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.30433770 |
| 73 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28927085 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26402723 |
| 75 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25640656 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23575297 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23153426 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22919677 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22748426 |
| 80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22486143 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22037779 |
| 82 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.21060247 |
| 83 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20482707 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20192066 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17725684 |
| 86 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17187470 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16014353 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15783229 |
| 89 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14379881 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13744548 |
| 91 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13727888 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.12988369 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12709716 |
| 94 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12348676 |
| 95 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12216448 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11619164 |
| 97 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11509071 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11220666 |
| 99 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10898575 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10627149 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10477958 |
| 102 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10453870 |
| 103 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10330369 |
| 104 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.09499808 |
| 105 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09150821 |
| 106 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06530868 |
| 107 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.05870823 |
| 108 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04704800 |
| 109 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01788337 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 0.99827072 |
| 111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99473252 |
| 112 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99296480 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 0.99039864 |
| 114 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99014665 |
| 115 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98532904 |
| 116 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98429565 |
| 117 | MYB_26560356_Chip-Seq_TH2_Human | 0.98199579 |
| 118 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97314564 |
| 119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.96631594 |
| 120 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96455519 |
| 121 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96115310 |
| 122 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95631611 |
| 123 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95251966 |
| 124 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94986346 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94169005 |
| 126 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90628459 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90544611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.36605082 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.39955135 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.23877868 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.19282379 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.17671557 |
| 6 | MP0003077_abnormal_cell_cycle | 3.06845543 |
| 7 | MP0005451_abnormal_body_composition | 2.94426720 |
| 8 | MP0008058_abnormal_DNA_repair | 2.75895028 |
| 9 | MP0008057_abnormal_DNA_replication | 2.66818555 |
| 10 | MP0008260_abnormal_autophagy | 2.54448634 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.46074930 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.30633177 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.30475292 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.19356242 |
| 15 | MP0001545_abnormal_hematopoietic_system | 2.19356242 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.18140717 |
| 17 | MP0004808_abnormal_hematopoietic_stem | 2.13339231 |
| 18 | MP0000685_abnormal_immune_system | 2.03312266 |
| 19 | MP0000490_abnormal_crypts_of | 2.01269698 |
| 20 | MP0002398_abnormal_bone_marrow | 1.97867528 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 1.87049525 |
| 22 | MP0001853_heart_inflammation | 1.85408213 |
| 23 | MP0001800_abnormal_humoral_immune | 1.80431236 |
| 24 | MP0003436_decreased_susceptibility_to | 1.80331174 |
| 25 | MP0000689_abnormal_spleen_morphology | 1.79965191 |
| 26 | MP0002722_abnormal_immune_system | 1.78897690 |
| 27 | MP0005671_abnormal_response_to | 1.76245979 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 1.73581060 |
| 29 | MP0008932_abnormal_embryonic_tissue | 1.69223813 |
| 30 | MP0000350_abnormal_cell_proliferation | 1.68415874 |
| 31 | MP0009278_abnormal_bone_marrow | 1.66001719 |
| 32 | MP0003786_premature_aging | 1.64752640 |
| 33 | MP0001730_embryonic_growth_arrest | 1.64325085 |
| 34 | MP0009785_altered_susceptibility_to | 1.64284406 |
| 35 | MP0002019_abnormal_tumor_incidence | 1.62247036 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.60484962 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.59920965 |
| 38 | MP0006082_CNS_inflammation | 1.58523852 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.57938533 |
| 40 | MP0000716_abnormal_immune_system | 1.57823704 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.57105130 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.55824107 |
| 43 | MP0002429_abnormal_blood_cell | 1.55668009 |
| 44 | MP0001819_abnormal_immune_cell | 1.54092964 |
| 45 | MP0002723_abnormal_immune_serum | 1.52949858 |
| 46 | MP0005025_abnormal_response_to | 1.51885181 |
| 47 | MP0005000_abnormal_immune_tolerance | 1.49453250 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.48099825 |
| 49 | MP0010307_abnormal_tumor_latency | 1.43786011 |
| 50 | MP0000313_abnormal_cell_death | 1.41753299 |
| 51 | MP0009840_abnormal_foam_cell | 1.41118702 |
| 52 | MP0002405_respiratory_system_inflammati | 1.39385582 |
| 53 | MP0009764_decreased_sensitivity_to | 1.39006861 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.36157644 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.34943893 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.32696205 |
| 57 | MP0003075_altered_response_to | 1.31699842 |
| 58 | MP0001727_abnormal_embryo_implantation | 1.31402182 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.27360325 |
| 60 | MP0002254_reproductive_system_inflammat | 1.25756056 |
| 61 | MP0001873_stomach_inflammation | 1.24783159 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.23444533 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.22354287 |
| 64 | MP0000343_altered_response_to | 1.20930422 |
| 65 | MP0000604_amyloidosis | 1.20536992 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.20490752 |
| 67 | MP0002080_prenatal_lethality | 1.18248429 |
| 68 | MP0002132_abnormal_respiratory_system | 1.17873093 |
| 69 | MP0002419_abnormal_innate_immunity | 1.17405034 |
| 70 | MP0001697_abnormal_embryo_size | 1.16951965 |
| 71 | MP0002163_abnormal_gland_morphology | 1.13964923 |
| 72 | MP0000858_altered_metastatic_potential | 1.13146050 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.09565381 |
| 74 | MP0001790_abnormal_immune_system | 1.08563479 |
| 75 | MP0005387_immune_system_phenotype | 1.08563479 |
| 76 | MP0005380_embryogenesis_phenotype | 1.07867117 |
| 77 | MP0001672_abnormal_embryogenesis/_devel | 1.07867117 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.06514561 |
| 79 | MP0003186_abnormal_redox_activity | 1.04982622 |
| 80 | MP0003567_abnormal_fetal_cardiomyocyte | 1.04340890 |
| 81 | MP0003718_maternal_effect | 1.02070762 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01232346 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.01230677 |
| 84 | MP0004947_skin_inflammation | 1.00733675 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.00448722 |
| 86 | MP0003984_embryonic_growth_retardation | 0.99555877 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.97849933 |
| 88 | MP0002088_abnormal_embryonic_growth/wei | 0.96770881 |
| 89 | MP0003866_abnormal_defecation | 0.95504933 |
| 90 | MP0000358_abnormal_cell_content/ | 0.94763801 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 0.92843266 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.91546013 |
| 93 | MP0002006_tumorigenesis | 0.91189088 |
| 94 | MP0003329_amyloid_beta_deposits | 0.91161925 |
| 95 | MP0005023_abnormal_wound_healing | 0.90348994 |
| 96 | MP0001542_abnormal_bone_strength | 0.89926222 |
| 97 | MP0003724_increased_susceptibility_to | 0.85893487 |
| 98 | MP0008469_abnormal_protein_level | 0.85810178 |
| 99 | MP0008995_early_reproductive_senescence | 0.85297069 |
| 100 | MP0006036_abnormal_mitochondrial_physio | 0.85259455 |
| 101 | MP0004510_myositis | 0.85140623 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.82954021 |
| 103 | MP0002095_abnormal_skin_pigmentation | 0.81616020 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.79488251 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.79486635 |
| 106 | MP0002085_abnormal_embryonic_tissue | 0.79468128 |
| 107 | MP0005166_decreased_susceptibility_to | 0.79193299 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.77908511 |
| 109 | MP0000598_abnormal_liver_morphology | 0.77368483 |
| 110 | MP0000477_abnormal_intestine_morphology | 0.77253826 |
| 111 | MP0005621_abnormal_cell_physiology | 0.77216274 |
| 112 | MP0009763_increased_sensitivity_to | 0.76472315 |
| 113 | MP0005310_abnormal_salivary_gland | 0.74907498 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.74042276 |
| 115 | MP0005384_cellular_phenotype | 0.73027542 |
| 116 | MP0003448_altered_tumor_morphology | 0.72682629 |
| 117 | MP0005266_abnormal_metabolism | 0.72383270 |
| 118 | MP0003303_peritoneal_inflammation | 0.72323818 |
| 119 | MP0001764_abnormal_homeostasis | 0.72110236 |
| 120 | MP0003566_abnormal_cell_adhesion | 0.72021212 |
| 121 | MP0002084_abnormal_developmental_patter | 0.72000188 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.71893708 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.71037577 |
| 124 | MP0001851_eye_inflammation | 0.70242757 |
| 125 | MP0002653_abnormal_ependyma_morphology | 0.70179362 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.69856453 |
| 127 | MP0004084_abnormal_cardiac_muscle | 0.69674558 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.68681446 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.68639535 |
| 130 | MP0000750_abnormal_muscle_regeneration | 0.66995404 |
| 131 | MP0000609_abnormal_liver_physiology | 0.66121722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.17979517 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.05332467 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 3.96978215 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.81292991 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.81292991 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.81292991 |
| 7 | Aplastic anemia (HP:0001915) | 3.66843795 |
| 8 | Thrombocytosis (HP:0001894) | 3.66460311 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 3.61900581 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.28180477 |
| 11 | Progressive muscle weakness (HP:0003323) | 3.27014798 |
| 12 | Stomatitis (HP:0010280) | 3.20551305 |
| 13 | Selective tooth agenesis (HP:0001592) | 3.19068904 |
| 14 | IgM deficiency (HP:0002850) | 3.17883062 |
| 15 | Oral leukoplakia (HP:0002745) | 3.17396226 |
| 16 | Reticulocytopenia (HP:0001896) | 3.17319118 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.15692517 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.09227078 |
| 19 | Increased IgM level (HP:0003496) | 3.09115790 |
| 20 | Abnormality of macrophages (HP:0004311) | 3.08259690 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 3.05977294 |
| 22 | Microretrognathia (HP:0000308) | 2.99207606 |
| 23 | Loss of speech (HP:0002371) | 2.89845265 |
| 24 | Petechiae (HP:0000967) | 2.81478181 |
| 25 | Multiple enchondromatosis (HP:0005701) | 2.78067594 |
| 26 | Ependymoma (HP:0002888) | 2.77352920 |
| 27 | Nasal polyposis (HP:0100582) | 2.77146166 |
| 28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73387791 |
| 29 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72515821 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 2.66319652 |
| 31 | Degeneration of anterior horn cells (HP:0002398) | 2.66235511 |
| 32 | Abnormality of the anterior horn cell (HP:0006802) | 2.66235511 |
| 33 | Cholecystitis (HP:0001082) | 2.65704500 |
| 34 | Abnormal gallbladder physiology (HP:0012438) | 2.65704500 |
| 35 | Rough bone trabeculation (HP:0100670) | 2.65482822 |
| 36 | Lymphoma (HP:0002665) | 2.65280139 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 2.63918827 |
| 38 | Obstructive lung disease (HP:0006536) | 2.62283033 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.62283033 |
| 40 | Breast hypoplasia (HP:0003187) | 2.61929389 |
| 41 | Increased serum ferritin (HP:0003281) | 2.59960603 |
| 42 | Medulloblastoma (HP:0002885) | 2.59908839 |
| 43 | Agnosia (HP:0010524) | 2.58305281 |
| 44 | Abnormality of T cells (HP:0002843) | 2.58270467 |
| 45 | Chronic otitis media (HP:0000389) | 2.58235475 |
| 46 | Recurrent viral infections (HP:0004429) | 2.58019223 |
| 47 | Pallor (HP:0000980) | 2.55306125 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.53381944 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.52555327 |
| 50 | Cerebral hypomyelination (HP:0006808) | 2.50689075 |
| 51 | Basal cell carcinoma (HP:0002671) | 2.50058674 |
| 52 | Amaurosis fugax (HP:0100576) | 2.46243851 |
| 53 | Vertebral compression fractures (HP:0002953) | 2.45749172 |
| 54 | Macrocytic anemia (HP:0001972) | 2.45309634 |
| 55 | Recurrent bronchitis (HP:0002837) | 2.44999704 |
| 56 | Patellar aplasia (HP:0006443) | 2.44754791 |
| 57 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.43690324 |
| 58 | Poikiloderma (HP:0001029) | 2.43095643 |
| 59 | Pancytopenia (HP:0001876) | 2.39754630 |
| 60 | Carpal bone hypoplasia (HP:0001498) | 2.39580135 |
| 61 | Axonal loss (HP:0003447) | 2.39137295 |
| 62 | Microvesicular hepatic steatosis (HP:0001414) | 2.37753317 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.36636823 |
| 64 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34253022 |
| 65 | Hypertensive crisis (HP:0100735) | 2.33698581 |
| 66 | Muscle fiber atrophy (HP:0100295) | 2.32734202 |
| 67 | Meningitis (HP:0001287) | 2.32543433 |
| 68 | Colon cancer (HP:0003003) | 2.32235993 |
| 69 | Abnormality of the prostate (HP:0008775) | 2.29137763 |
| 70 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.28744761 |
| 71 | Systemic lupus erythematosus (HP:0002725) | 2.28670925 |
| 72 | Premature graying of hair (HP:0002216) | 2.28080371 |
| 73 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.28076857 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.27235765 |
| 75 | Colitis (HP:0002583) | 2.26652786 |
| 76 | Gastrointestinal inflammation (HP:0004386) | 2.26146447 |
| 77 | IgG deficiency (HP:0004315) | 2.26097131 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.24349005 |
| 79 | Myelodysplasia (HP:0002863) | 2.24302973 |
| 80 | Urticaria (HP:0001025) | 2.23860844 |
| 81 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.23640517 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.21702911 |
| 83 | Prolonged neonatal jaundice (HP:0006579) | 2.18642629 |
| 84 | Increased muscle lipid content (HP:0009058) | 2.18148486 |
| 85 | Orchitis (HP:0100796) | 2.16922248 |
| 86 | Type I transferrin isoform profile (HP:0003642) | 2.15764665 |
| 87 | Prolonged bleeding time (HP:0003010) | 2.15311177 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14400389 |
| 89 | Pustule (HP:0200039) | 2.14261788 |
| 90 | Upper motor neuron abnormality (HP:0002127) | 2.13892900 |
| 91 | Achilles tendon contracture (HP:0001771) | 2.12814698 |
| 92 | Neoplasm of the pancreas (HP:0002894) | 2.12417481 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11247194 |
| 94 | Myositis (HP:0100614) | 2.10713081 |
| 95 | T lymphocytopenia (HP:0005403) | 2.10375093 |
| 96 | Acute lymphatic leukemia (HP:0006721) | 2.09697879 |
| 97 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.09421071 |
| 98 | Broad distal phalanx of finger (HP:0009836) | 2.09125089 |
| 99 | Bone marrow hypocellularity (HP:0005528) | 2.08335472 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 2.07976219 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07700844 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07700844 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07700844 |
| 104 | Type 2 muscle fiber atrophy (HP:0003554) | 2.07426888 |
| 105 | Progressive neurologic deterioration (HP:0002344) | 2.07383673 |
| 106 | Abnormal platelet function (HP:0011869) | 2.06638372 |
| 107 | Impaired platelet aggregation (HP:0003540) | 2.06638372 |
| 108 | Lymphopenia (HP:0001888) | 2.05568507 |
| 109 | Encephalitis (HP:0002383) | 2.05098006 |
| 110 | Entropion (HP:0000621) | 2.04739276 |
| 111 | Gingivitis (HP:0000230) | 2.04495006 |
| 112 | Increased IgE level (HP:0003212) | 2.03297745 |
| 113 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03273557 |
| 114 | Recurrent fungal infections (HP:0002841) | 2.02745066 |
| 115 | Inflammation of the large intestine (HP:0002037) | 2.01559164 |
| 116 | Thoracic kyphosis (HP:0002942) | 2.01448839 |
| 117 | Purpura (HP:0000979) | 2.00491088 |
| 118 | Agammaglobulinemia (HP:0004432) | 1.98511485 |
| 119 | Recurrent skin infections (HP:0001581) | 1.97829145 |
| 120 | Abnormality of T cell number (HP:0011839) | 1.97564719 |
| 121 | Neuronal loss in central nervous system (HP:0002529) | 1.97106238 |
| 122 | Ragged-red muscle fibers (HP:0003200) | 1.95761628 |
| 123 | Retrobulbar optic neuritis (HP:0100654) | 1.95626708 |
| 124 | Optic neuritis (HP:0100653) | 1.95626708 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.95146635 |
| 126 | Cerebellar dysplasia (HP:0007033) | 1.95117826 |
| 127 | Autoimmune hemolytic anemia (HP:0001890) | 1.95001829 |
| 128 | Granulocytopenia (HP:0001913) | 1.94045276 |
| 129 | Prostate neoplasm (HP:0100787) | 1.93617542 |
| 130 | Cellular immunodeficiency (HP:0005374) | 1.92893619 |
| 131 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.92732856 |
| 132 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.92732856 |
| 133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92663350 |
| 134 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92663350 |
| 135 | Autoimmune thrombocytopenia (HP:0001973) | 1.92624614 |
| 136 | Albinism (HP:0001022) | 1.92552986 |
| 137 | Hepatocellular necrosis (HP:0001404) | 1.92122238 |
| 138 | IgA deficiency (HP:0002720) | 1.91933719 |
| 139 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91550398 |
| 140 | Abnormality of B cell number (HP:0010975) | 1.91520147 |
| 141 | B lymphocytopenia (HP:0010976) | 1.91520147 |
| 142 | CNS hypomyelination (HP:0003429) | 1.91446235 |
| 143 | Vasculitis (HP:0002633) | 1.89878467 |
| 144 | Peripheral hypomyelination (HP:0007182) | 1.89456441 |
| 145 | Combined immunodeficiency (HP:0005387) | 1.88894672 |
| 146 | Rhabdomyosarcoma (HP:0002859) | 1.88393346 |
| 147 | Trismus (HP:0000211) | 1.88372004 |
| 148 | Recurrent abscess formation (HP:0002722) | 1.87652691 |
| 149 | Pulmonary fibrosis (HP:0002206) | 1.86737024 |
| 150 | Progressive external ophthalmoplegia (HP:0000590) | 1.86558468 |
| 151 | 11 pairs of ribs (HP:0000878) | 1.85156008 |
| 152 | Premature ovarian failure (HP:0008209) | 1.84626143 |
| 153 | Absent thumb (HP:0009777) | 1.84012424 |
| 154 | Opisthotonus (HP:0002179) | 1.83332202 |
| 155 | Epistaxis (HP:0000421) | 1.83206739 |
| 156 | Leukopenia (HP:0001882) | 1.83106681 |
| 157 | Poor head control (HP:0002421) | 1.82832709 |
| 158 | Cellulitis (HP:0100658) | 1.82576395 |
| 159 | Abnormal trabecular bone morphology (HP:0100671) | 1.78814612 |
| 160 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.77059264 |
| 161 | Abnormality of eosinophils (HP:0001879) | 1.75203306 |
| 162 | Chromsome breakage (HP:0040012) | 1.75137204 |
| 163 | Optic nerve coloboma (HP:0000588) | 1.74840669 |
| 164 | Prominent nose (HP:0000448) | 1.74336854 |
| 165 | Abnormality of the preputium (HP:0100587) | 1.74014245 |
| 166 | Abnormality of the ileum (HP:0001549) | 1.73707555 |
| 167 | Abnormal number of incisors (HP:0011064) | 1.72155561 |
| 168 | Squamous cell carcinoma (HP:0002860) | 1.70697060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.73775927 |
| 2 | WEE1 | 3.61565407 |
| 3 | MAP4K1 | 3.07285258 |
| 4 | EIF2AK1 | 2.57416139 |
| 5 | MAP3K10 | 2.53453887 |
| 6 | PRPF4B | 2.51421556 |
| 7 | NME2 | 2.36540640 |
| 8 | TESK1 | 2.24199310 |
| 9 | PIK3CG | 2.23572614 |
| 10 | STK16 | 2.20552530 |
| 11 | FLT3 | 2.17498587 |
| 12 | SMG1 | 2.15479662 |
| 13 | VRK2 | 2.14990370 |
| 14 | KIT | 2.14171566 |
| 15 | TAOK2 | 2.12818295 |
| 16 | NEK2 | 2.09060528 |
| 17 | CDC7 | 1.95687328 |
| 18 | ICK | 1.89076884 |
| 19 | ARAF | 1.81344969 |
| 20 | TESK2 | 1.79273469 |
| 21 | DYRK3 | 1.78107985 |
| 22 | RPS6KA4 | 1.70730238 |
| 23 | EEF2K | 1.67667980 |
| 24 | EIF2AK3 | 1.65763561 |
| 25 | PIM2 | 1.65417204 |
| 26 | CDK7 | 1.61727006 |
| 27 | STK10 | 1.56202422 |
| 28 | ZAP70 | 1.44713277 |
| 29 | ACVR1B | 1.44085420 |
| 30 | PKN2 | 1.43994562 |
| 31 | PLK4 | 1.43710721 |
| 32 | KDR | 1.43182874 |
| 33 | MAP3K14 | 1.42316086 |
| 34 | RPS6KB2 | 1.40926818 |
| 35 | PLK1 | 1.39809158 |
| 36 | BRSK2 | 1.37040512 |
| 37 | JAK3 | 1.36580424 |
| 38 | BCKDK | 1.34146678 |
| 39 | CSF1R | 1.33748512 |
| 40 | TGFBR1 | 1.30624682 |
| 41 | TYK2 | 1.30204972 |
| 42 | TAOK1 | 1.28588992 |
| 43 | TSSK6 | 1.28310233 |
| 44 | ERN1 | 1.27597770 |
| 45 | CDK4 | 1.26895150 |
| 46 | NEK1 | 1.25736185 |
| 47 | ATR | 1.25657591 |
| 48 | BTK | 1.25108721 |
| 49 | RIPK4 | 1.25071019 |
| 50 | PAK4 | 1.22172989 |
| 51 | MAP2K3 | 1.21515614 |
| 52 | VRK1 | 1.19886985 |
| 53 | MAP3K11 | 1.18063410 |
| 54 | SRPK1 | 1.18050304 |
| 55 | PIM1 | 1.17654866 |
| 56 | CCNB1 | 1.16604609 |
| 57 | PASK | 1.12775730 |
| 58 | AURKB | 1.12553736 |
| 59 | LIMK1 | 1.09916782 |
| 60 | BLK | 1.09867781 |
| 61 | FES | 1.09239393 |
| 62 | BRAF | 1.09123150 |
| 63 | MAP3K8 | 1.07578980 |
| 64 | TBK1 | 1.06881771 |
| 65 | GRK7 | 1.06611640 |
| 66 | TEC | 1.04952247 |
| 67 | TTK | 1.04329848 |
| 68 | GRK6 | 1.03088287 |
| 69 | TXK | 1.02316038 |
| 70 | MATK | 1.00879628 |
| 71 | MKNK1 | 0.99022277 |
| 72 | TNK2 | 0.96890331 |
| 73 | IKBKB | 0.96578020 |
| 74 | IRAK3 | 0.93641760 |
| 75 | LRRK2 | 0.93068604 |
| 76 | TRIB3 | 0.92517023 |
| 77 | PBK | 0.90437086 |
| 78 | ABL2 | 0.90403819 |
| 79 | MAP3K3 | 0.85952928 |
| 80 | SCYL2 | 0.82655407 |
| 81 | CHEK2 | 0.82329824 |
| 82 | TGFBR2 | 0.81635584 |
| 83 | CDK12 | 0.80871900 |
| 84 | STK4 | 0.79772660 |
| 85 | IKBKE | 0.78308379 |
| 86 | CHUK | 0.77289600 |
| 87 | SYK | 0.77026972 |
| 88 | BRSK1 | 0.76875961 |
| 89 | CSNK1G3 | 0.76203181 |
| 90 | SIK3 | 0.75519185 |
| 91 | AURKA | 0.75275064 |
| 92 | IRAK4 | 0.74734767 |
| 93 | TAF1 | 0.69824118 |
| 94 | RPS6KA5 | 0.68296543 |
| 95 | EPHB1 | 0.66169019 |
| 96 | CHEK1 | 0.65719595 |
| 97 | MAPK11 | 0.64744105 |
| 98 | MARK3 | 0.63575785 |
| 99 | RPS6KC1 | 0.62697648 |
| 100 | RPS6KL1 | 0.62697648 |
| 101 | MAPKAPK3 | 0.62274438 |
| 102 | MAP2K2 | 0.61322192 |
| 103 | CDK8 | 0.59029583 |
| 104 | LYN | 0.58061906 |
| 105 | BMX | 0.57782465 |
| 106 | MAP3K1 | 0.57257649 |
| 107 | LCK | 0.57114922 |
| 108 | HCK | 0.55653343 |
| 109 | IRAK2 | 0.55523311 |
| 110 | CSNK1A1L | 0.55293136 |
| 111 | RPS6KA2 | 0.53381522 |
| 112 | DAPK3 | 0.52483634 |
| 113 | HIPK2 | 0.52361196 |
| 114 | PRKD2 | 0.51713546 |
| 115 | RAF1 | 0.51647828 |
| 116 | PAK1 | 0.51600081 |
| 117 | CDK2 | 0.51387211 |
| 118 | FGR | 0.51218307 |
| 119 | FGFR4 | 0.49644465 |
| 120 | SIK2 | 0.49279422 |
| 121 | CSNK2A1 | 0.46939988 |
| 122 | MOS | 0.46409012 |
| 123 | TLK1 | 0.45080363 |
| 124 | PDK2 | 0.44224208 |
| 125 | CSNK2A2 | 0.43823948 |
| 126 | PRKCI | 0.43110215 |
| 127 | RIPK1 | 0.42968537 |
| 128 | CDK6 | 0.42667180 |
| 129 | MKNK2 | 0.42024205 |
| 130 | TAOK3 | 0.41971191 |
| 131 | EPHA2 | 0.41438728 |
| 132 | ILK | 0.40845979 |
| 133 | MAP2K6 | 0.39999374 |
| 134 | ALK | 0.39846062 |
| 135 | AKT2 | 0.39840827 |
| 136 | ITK | 0.39572584 |
| 137 | DAPK1 | 0.39170753 |
| 138 | DYRK1B | 0.35921559 |
| 139 | ATM | 0.35056915 |
| 140 | RPS6KA6 | 0.34064876 |
| 141 | CSK | 0.33635224 |
| 142 | CDK19 | 0.33236848 |
| 143 | RPS6KA1 | 0.32590805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.87350541 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.01506305 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.49156393 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.01677693 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.01283771 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.95892270 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.85881547 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.72290005 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.49876453 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.45773104 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.32988581 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.30562630 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.17073516 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 2.12092265 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.08547436 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72262943 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65335233 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.64417503 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62773443 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.54647444 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52569007 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42569335 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.41239864 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.39327648 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33693730 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.31553176 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.31423351 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31363145 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30942664 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26309201 |
| 31 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.22745370 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.18932447 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.17312006 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.15026543 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13920736 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.13161313 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10923274 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10826914 |
| 39 | Purine metabolism_Homo sapiens_hsa00230 | 1.10721148 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09122985 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.08517847 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08493885 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08044888 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.07898114 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06968931 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.06826727 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.06276958 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04265512 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.01456163 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.00890335 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.97236230 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95014092 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92973594 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91641181 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90452016 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 0.88080859 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87905583 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85513770 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84941063 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84151608 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.83586304 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81620801 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81136552 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80180193 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.77530340 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75203772 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74509281 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74341769 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72675998 |
| 70 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72271995 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72246479 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71371619 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.70763008 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.70080441 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67491534 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65167877 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64958736 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.64315547 |
| 79 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61565896 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61405985 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61270789 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.60873402 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.59711915 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59225243 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59138758 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59048980 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58119561 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.57066652 |
| 89 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56562198 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55503444 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55385030 |
| 92 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55135733 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54706125 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53726808 |
| 95 | Asthma_Homo sapiens_hsa05310 | 0.52408986 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51285271 |
| 97 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51116330 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49649815 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49254253 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49116926 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48858872 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47846532 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47166068 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46353812 |
| 105 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46211948 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45471213 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45441182 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44508294 |
| 109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44497437 |
| 110 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44173659 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40486098 |
| 112 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40293067 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39796893 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37796423 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37619076 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36402740 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34361579 |
| 118 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34179988 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32501590 |
| 120 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.30910002 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30194763 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29074572 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28598944 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28030715 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26638607 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.26252963 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24578979 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.23949075 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.22535198 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.20875082 |

